Netherlands-based company providing services in three divisions; radiological diagnostics, clinical laboratory and cancer treatment, in 180 medical centres.
Until now the company operated in Poland, Hungary, Romania, Bosnia and Herzegovina, Croatia, Greece, Italy, Turkey, Czech Republic, Ireland, Switzerland, Lithuania, Bulgaria, Serbia and Portugal. With the acquisition of Q-Diagnostica, Affidea enters the Spanish market.
Euromedic began to grow in 2000 when GE Equity and Dresdner Kleinwort Benson entered the company. This allowed the company to expand into countries such as Poland and Romania and to make acquisitions such as Red Sea Group. In 2005 GE bought the whole company and boosted its activity throughout Europe, doubling its activity and making acquisitions such as Cientia in Portugal.
In 2008 Merrill Lynch Global Private Equity (MLGPE), Ares Life Sciences, Montagu Private Equity and Management jointly acquired the company from Warburg Pincus and GE Capital Equity. The firm turned around and focused primarily on diagnostic imaging.
In 2015 Euromedic changed its name to Affidea.
Q-Diagnostica is a leading Spanish diagnostic imaging company that incorporates the most advanced technology in Magnetic Resonance Imaging, CT and PET-CT techniques. Q-Diagnostica develops, manages, supports and promotes centres through its extensive nationwide network.
The firm is owned by Mercapital, which merged with N+1 in 2012.
Q-Diagnostica, has been declining in turnover for a number of years and the union with Affidea will allow it to gain the necessary momentum to become a leader in the Spanish market.
From our business unit LogicFin we have made a study on investment in technology companies in the field of diagnostic imaging that we would like to share with you. You can get it by calling + 34 946424142 or filling in the contact form.